As of June 5, 2025, Covetrus Inc (CVET) reports a Gross Margin of 18.75%.
Gross Margin indicates the portion of sales revenue remaining after covering production costs, highlighting operational efficiency.
Historical Trend of Covetrus Inc's Gross Margin
Over recent years, Covetrus Inc's Gross Margin has shown a stable trend. The table below summarizes the historical values:
| Date | Gross Margin |
|---|---|
| 2021-12-31 | 18.75% |
| 2020-12-31 | 18.39% |
| 2019-12-31 | 18.84% |
| 2018-12-29 | 18.11% |
| 2017-12-30 | 18.21% |
This fluctuation highlights how Covetrus Inc manages its operational efficiency and pricing power over time.
Comparing Covetrus Inc's Gross Margin to Peers
To better understand Covetrus Inc's position, it's useful to compare its Gross Margin against industry peers. Below are selected comparisons:
| Company | Gross Margin |
|---|---|
| Covetrus Inc (CVET) | 18.75% |
| Apria Inc (APR) | 70.20% |
| Henry Schein Inc (HSIC) | 31.69% |
| Adapthealth Corp (AHCO) | 23.78% |
| PetIQ Inc (PETQ) | 22.94% |
| ACRO Biomedical Co Ltd (ACBM) | 21.21% |
Compared to its competitors, Covetrus Inc's Gross Margin is about average compared to peers, indicating industry-standard operational efficiency.